Gujarat Inject Kerala Ltd — Quarterly Results & Earnings

₹78.21

+0.68%

Profit Growth YoY-88.52%Latest quarter

Sales Growth YoY-81.65%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth-88.52%

🔴 Significant decline

YoY Sales Growth-81.65%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

2.32%

EPS Growth 5Y

104.89%

Interest Coverage

Higher = safer debt servicing

N/A

ROE

11.00%

ROCE

13.48%

💡

Growth Analysis

Gujarat Inject Kerala Ltd reported YoY profit growth of -88.52% and revenue growth of -81.65% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Gujarat Inject Kerala Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.